SAMANCI, C. Et Al. 2019. Diagnostic Capabilities of MRI Versus F-18 FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, I-131-negative Local Recurrent or Metastatic Thyroid Cancer. CURRENT MEDICAL IMAGING , vol.15, no.10 , 956-964.

SAMANCI, C., Onal, Y., SAĞER, M. S., Asa, S., Ustabasioglu, F. E., Alis, D. C., ... Akman, C.(2019). Diagnostic Capabilities of MRI Versus F-18 FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, I-131-negative Local Recurrent or Metastatic Thyroid Cancer. CURRENT MEDICAL IMAGING , vol.15, no.10, 956-964.

SAMANCI, Cesur Et Al. "Diagnostic Capabilities of MRI Versus F-18 FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, I-131-negative Local Recurrent or Metastatic Thyroid Cancer," CURRENT MEDICAL IMAGING , vol.15, no.10, 956-964, 2019

SAMANCI, Cesur Et Al. "Diagnostic Capabilities of MRI Versus F-18 FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, I-131-negative Local Recurrent or Metastatic Thyroid Cancer." CURRENT MEDICAL IMAGING , vol.15, no.10, pp.956-964, 2019

SAMANCI, C. Et Al. (2019) . "Diagnostic Capabilities of MRI Versus F-18 FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, I-131-negative Local Recurrent or Metastatic Thyroid Cancer." CURRENT MEDICAL IMAGING , vol.15, no.10, pp.956-964.

@article{article, author={Cesur SAMANCI Et Al. }, title={Diagnostic Capabilities of MRI Versus F-18 FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, I-131-negative Local Recurrent or Metastatic Thyroid Cancer}, journal={CURRENT MEDICAL IMAGING}, year=2019, pages={956-964} }